Comparing efficacy and safety of regorafenib versus pemetrexed in lung cancer: A preliminary clinical trial evaluating effect of inflammatory biomarkers on disease progression
Page No: 1293-1299
By: Yuanshan Yao, Yinjie Zhou, Qingwang Hua
Keywords: Regorafenib, pemetrexed, Chinese, early stage of lung cancer, inflammatory biomarkers
Abstract: This pilot clinical trial was designed to compare the efficacy and safety of regorafenib versus pemetrexed in Chinese patients with early stage of lung cancer.
[View Complete Article]